Non-muscle-invasive bladder cancer: a vision for the future




Per-Uno Malmström, Sachin Agrawal, Mats Bläckberg, Peter J. Boström, Bernard Malavaud, Dirk Zaak, Gregers G. Hermann

PublisherTAYLOR & FRANCIS LTD

2017

Scandinavian Journal of Urology

SCANDINAVIAN JOURNAL OF UROLOGY

SCAND J UROL

51

2

87

94

8

2168-1805

2168-1813

DOIhttps://doi.org/10.1080/21681805.2017.1283359

https://research.utu.fi/converis/portal/detail/Publication/26591980



The management of non-muscle-invasive bladder cancer (NMIBC) has evolved from the first reports on bladder endoscopy and transurethral resection to the introduction of adjuvant intravesical treatment. However, disease recurrence and progression remain an ongoing risk, placing a heavy burden on healthcare resources and on patients' quality of life. Deeper understanding of the molecular basis of the disease and developments in optics, lasers and computer science are already offering opportunities to revolutionize care and improve long-term prognosis. This article discusses developments likely to cause a paradigm shift towards the delivery of personalized care and reduced burden of disease in NMIBC.

Last updated on 2024-26-11 at 10:27